本页面由Tiger Trade Technology Pte. Ltd.提供服务

RAPT Therapeutics, Inc.

58.02
0.0000
成交量:- -
成交额:- -
市值:16.80亿
市盈率:-4.98
高:58.02
开:58.02
低:58.02
收:58.02
52周最高:58.02
52周最低:5.67
股本:2,896.06万
流通股本:2,580.75万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-11.6600
每股收益(LYR):-25.4880
净资产收益率:-85.37%
总资产收益率:-51.35%
市净率:11.06
市盈率(LYR):-2.28

数据加载中...

2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/03

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/03/03

重要事件披露

Form 8-K - Current report
2026/01/20

重要事件披露

Form 8-K - Current report
2026/01/14

重要事件披露

Form 8-K - Current report
2025/11/28

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/23

重要事件披露

Form 8-K - Current report
2025/10/20

重要事件披露

Form 8-K - Current report
2025/08/07

重要事件披露

Form 8-K - Current report
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/08

重要事件披露

Form 8-K - Current report